Literature DB >> 23151837

Health-related quality of life and psychological states in patients with pulmonary arterial hypertension.

Lea Ann Matura1, Annette McDonough, Diane L Carroll.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is a chronic illness that impairs physical function and leads to right-sided heart failure and premature death. There is limited knowledge on health-related quality of life (HRQOL) and psychological states in patients with PAH.
OBJECTIVE: The aim of this study was to determine the HRQOL and the psychological states of patients with PAH along with predictors of HRQOL.
METHODS: In a cross-sectional design, participants with PAH completed the Medical Outcomes Study Short Form-36 v2 to measure generic HRQOL, the US Cambridge Pulmonary Hypertension Outcome Review to measure disease-specific HRQOL, and the Profile of Mood States to measure the psychological states. Descriptive statistics were used to calculate all sociodemographic and clinical data and were expressed as means and standard deviations for continuous variables and as frequencies and proportions for dichotomous and nominal variables. The statistical significance level was set at P < 0.05. A multiple linear regression analysis was performed to examine the sociodemographic and clinical variables as predictors of HRQOL. A bivariate analysis of the sociodemographic and clinical variables was performed to determine correlates with HRQOL. The variables that correlated with HRQOL at the 0.20 level of significance were included.
RESULTS: There were 149 participants, 127 women and 22 men, with a mean age of 53.5 years. The participants demonstrated diminished general health, physical functioning, role physical, and vitality on the Short Form-36 v2. Functional class, education level, oxygen use, years since diagnosis, and calcium channel blocker therapy were predictive of poorer HRQOL.
CONCLUSIONS: Patients with PAH are experiencing diminished physical health and HRQOL. Future studies are needed to design and test interventions to improve HRQOL.

Entities:  

Mesh:

Year:  2014        PMID: 23151837     DOI: 10.1097/JCN.0b013e318275330d

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  16 in total

1.  Physical Activity and Symptoms in Pulmonary Arterial Hypertension.

Authors:  Lea Ann Matura; Haochang Shou; Jason S Fritz; K Akaya Smith; Anjali Vaidya; Diane Pinder; Christine Archer-Chicko; Danielle Dubow; Harold I Palevsky; Marilyn S Sommers; Steven M Kawut
Journal:  Chest       Date:  2016-02-15       Impact factor: 9.410

2.  Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.

Authors:  Lea Ann Matura; Corey E Ventetuolo; Harold I Palevsky; David J Lederer; Evelyn M Horn; Stephen C Mathai; Diane Pinder; Christine Archer-Chicko; Emilia Bagiella; Kari E Roberts; Russell P Tracy; Paul M Hassoun; Reda E Girgis; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 3.  Muscle training in patients with pulmonary hypertension. a narrative review.

Authors:  Vicente Benavides-Cordoba; Martijn A Spruit
Journal:  Colomb Med (Cali)       Date:  2021-12-30

Review 4.  Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.

Authors:  Shuyan Gu; Huimei Hu; Hengjin Dong
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

5.  Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.

Authors:  Lea Ann Matura; Annette McDonough; Diane L Carroll
Journal:  J Pain Symptom Manage       Date:  2015-08-20       Impact factor: 3.612

6.  Effect of self - care education on quality of life in patients with primary hypertension: comparing lecture and educational package.

Authors:  Mohamad Aghajani; Neda Mirbagher Ajorpaz; Mahbube Kafaei Atrian; Zahra Raofi; Fatemeh Abedi; Sajad Naeimi Vartoni; Akbar Soleimani
Journal:  Nurs Midwifery Stud       Date:  2013-12-09

7.  Quality of life among pulmonary hypertension patients in Finland.

Authors:  Merja Kukkonen; Airi Puhakka; Maija Halme
Journal:  Eur Clin Respir J       Date:  2016-01-18

8.  Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  Dominik Harzheim; Hans Klose; Fabiola Peña Pinado; Nicola Ehlken; Christian Nagel; Christine Fischer; Ardeschir Ghofrani; Stephan Rosenkranz; Hans-Jürgen Seyfarth; Michael Halank; Eckhard Mayer; Ekkehard Grünig; Stefan Guth
Journal:  Respir Res       Date:  2013-10-09

9.  Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.

Authors:  Abílio Reis; James Twiss; Margarida Vicente; Fabienne Gonçalves; Luísa Carvalho; José Meireles; Alzira Melo; Stephen P McKenna; Luís Almeida
Journal:  Health Qual Life Outcomes       Date:  2016-07-26       Impact factor: 3.186

10.  Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study.

Authors:  Kathleen Morrisroe; Molla Huq; Wendy Stevens; Candice Rabusa; Susanna M Proudman; Mandana Nikpour
Journal:  BMC Pulm Med       Date:  2016-09-27       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.